130 related articles for article (PubMed ID: 20734711)
1. Inverted CD4+/CD8+ ratio associated with AIDS event and death in HIV-1 infected individuals in Nasarawa State, Nigeria.
Forbi JC; Agwale SM
Tanzan J Health Res; 2009 Jul; 11(3):144-8. PubMed ID: 20734711
[TBL] [Abstract][Full Text] [Related]
2. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.
Leung V; Gillis J; Raboud J; Cooper C; Hogg RS; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Klein MB;
PLoS One; 2013; 8(10):e77665. PubMed ID: 24204912
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria.
Ajayi AO; Ajayi EA; Fasakin KA
Ann Afr Med; 2009; 8(4):257-60. PubMed ID: 20139549
[TBL] [Abstract][Full Text] [Related]
5. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
6. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.
Kaufmann GR; Bloch M; Finlayson R; Zaunders J; Smith D; Cooper DA
AIDS; 2002 Feb; 16(3):359-67. PubMed ID: 11834947
[TBL] [Abstract][Full Text] [Related]
7. CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients.
Ray K; Gupta SM; Bala M; Muralidhar S; Kumar J
Indian J Med Res; 2006 Sep; 124(3):319-30. PubMed ID: 17085836
[TBL] [Abstract][Full Text] [Related]
8. Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau.
Lisse IM; Poulsen AG; Aaby P; Knudsen K; Dias F
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):355-62. PubMed ID: 8948374
[TBL] [Abstract][Full Text] [Related]
9. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group.
Livingstone WJ; Moore M; Innes D; Bell JE; Simmonds P
Lancet; 1996 Sep; 348(9028):649-54. PubMed ID: 8782755
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T-lymphocyte count/CD8+ T-lymphocyte count ratio: surrogate for HIV infection in infants?
Navaneethapandian PG; Karunaianantham R; Subramanyan S; Chinnayan P; Chandrasekaran P; Swaminathan S
J Trop Pediatr; 2012 Oct; 58(5):394-7. PubMed ID: 22228820
[TBL] [Abstract][Full Text] [Related]
11. Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.
Caby F; Guihot A; Lambert-Niclot S; Guiguet M; Boutolleau D; Agher R; Valantin MA; Tubiana R; Calvez V; Marcelin AG; Carcelain G; Autran B; Costagliola D; Katlama C
Clin Infect Dis; 2016 May; 62(10):1297-1303. PubMed ID: 26908792
[TBL] [Abstract][Full Text] [Related]
12. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population.
Roman M; Rodriguez JW; Pagán NO; Rios-Olivares E; Amill A; Hunter R
P R Health Sci J; 2002 Sep; 21(3):195-201. PubMed ID: 12243109
[TBL] [Abstract][Full Text] [Related]
13. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
[TBL] [Abstract][Full Text] [Related]
14. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
15. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
[TBL] [Abstract][Full Text] [Related]
16. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CD4 counts and percentages in the HIV infected Indian population.
Vajpayee M; Kanswal S; Wig N; Seth P
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):144-6. PubMed ID: 15272758
[TBL] [Abstract][Full Text] [Related]
18. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events.
Serrano-Villar S; Wu K; Hunt PW; Lok JJ; Ron R; Sainz T; Moreno S; Deeks SG; Bosch RJ
EBioMedicine; 2022 Jun; 80():104072. PubMed ID: 35644125
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.
Gras L; May M; Ryder LP; Trickey A; Helleberg M; Obel N; Thiebaut R; Guest J; Gill J; Crane H; Dias Lima V; dʼArminio Monforte A; Sterling TR; Miro J; Moreno S; Stephan C; Smith C; Tate J; Shepherd L; Saag M; Rieger A; Gillor D; Cavassini M; Montero M; Ingle SM; Reiss P; Costagliola D; Wit FWNM; Sterne J; de Wolf F; Geskus R;
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):292-300. PubMed ID: 30531492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
